B ioresorbable scaffolds (BRS) are promising devices for the treatment of coronary artery disease by virtue of their resorption properties allowing positive vascular remodeling. 1, 2 This case report illustrates the vascular healing process after Absorb BRS (Abbott Vascular, Santa Clara, CA) implantation in a false lumen during the treatment of a chronic total occlusion.
B ioresorbable scaffolds (BRS) are promising devices for the treatment of coronary artery disease by virtue of their resorption properties allowing positive vascular remodeling. 1, 2 This case report illustrates the vascular healing process after Absorb BRS (Abbott Vascular, Santa Clara, CA) implantation in a false lumen during the treatment of a chronic total occlusion.
A 62-year-old male with stable angina underwent coronary angiography revealing a chronic total occlusion of the left anterior descending artery. Percutaneous coronary intervention was attempted via the anterograde approach. A hydrophilic Fielder FC wire (ASAHI Intecc, Tokyo, Japan) entered the subintimal space ( Figure [1] ) supported by a 1.25 mm over-the-wire semicompliant balloon. The wire reentered the true lumen distally and after predilation, 4 minimally overlapping Absorb (Abbott Vascular) BRS were implanted in the left anterior descending artery ( Figure [1 and 2] ). Although, there was a remaining dissection distal to the implanted BRS, further scaffold/stent implantation was not performed because of small vessel size and good distal flow. Intravascular imaging was not performed because of these concerns.
Optical frequency domain imaging (LUNAWAVE, Terumo Corporation, Tokyo, Japan) performed at 13-month follow-up demonstrated a healed false lumen smoothly covered with neointima. The compressed true lumen was also patent and supplied by collateral flow (Figure [B-E] ). Furthermore, optical frequency domain imaging revealed smooth neointimal growth over the distal edge of the BRS (Figure [A] ; Movie I in the Data Supplement). This case demonstrates the vascular healing process of a false lumen after a chronic total occlusion percutaneous coronary intervention with current BRS.
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